BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26995659)

  • 1. Cytokine-induced STAT1 activation is increased in patients with primary Sjögren's syndrome.
    Pertovaara M; Silvennoinen O; Isomäki P
    Clin Immunol; 2016 Apr; 165():60-7. PubMed ID: 26995659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
    Pertovaara M; Silvennoinen O; Isomäki P
    Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.
    Davies R; Hammenfors D; Bergum B; Vogelsang P; Gavasso S; Brun JG; Jonsson R; Appel S
    Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
    Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
    Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome.
    Alunno A; Montanucci P; Bistoni O; Basta G; Caterbi S; Pescara T; Pennoni I; Bini V; Bartoloni E; Gerli R; Calafiore R
    Rheumatology (Oxford); 2015 Jan; 54(1):163-8. PubMed ID: 25065014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of STAT1 and STAT4 Expression by Growth Factor and Interferon Supplementation in Sjögren's Syndrome Cell Culture Models.
    Mougeot JC; Thornburg TE; Noll BD; Brennan MT; Mougeot FB
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
    Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
    Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Chen JQ; Zilahi E; Papp G; Sipka S; Zeher M
    Int J Rheum Dis; 2017 May; 20(5):609-613. PubMed ID: 26620207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
    Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
    Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeoniflorin down-regulates ATP-induced inflammatory cytokine production and P2X7R expression on peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
    Yu J; Chen Y; Li M; Gao Q; Peng Y; Gong Q; Zhang Z; Wu X
    Int Immunopharmacol; 2015 Sep; 28(1):115-20. PubMed ID: 26049028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.